Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: Prominence of interleukin 4 in restricted disease

Journal of Rheumatology

Volumn 25, Issue 7, 1998, Pages 1388-1398

  Murray, Kevin J ^a   Grom, Alexei A ^a   Thompson, Susan D ^a,b   Lieuwen, David ^a   Passo, Murray H ^a,b   Glass, David N ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Department of Pediatrics ^*

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cytokines; IL 4; Juvenile rheumatoid arthritis; Juvenile spondyloarthropathy

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOTOXIN; MESSENGER RNA;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; JUVENILE RHEUMATOID ARTHRITIS; MALE; MONONUCLEAR CELL; ONSET AGE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONDYLOARTHROPATHY; SYNOVIUM;

ADOLESCENT; ADULT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HLA ANTIGENS; HUMANS; INFANT; INTERLEUKIN-4; MALE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPONDYLITIS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 0031809101     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996;14:397-440.
2. Salgame P, Abrams JS, Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991;254:279-82.
3. Seder RA, Le Gros GG. The functional role of CD8+ T helper type 2 cells. J Exp Med 1995;181:5-7.
4. Seder RA, Boulay JL, Finkelman F, et al. CD8+ cells can be primed in vitro to produce IL-4. J Immunol 1992;148:1652-6.
5. Schlaak J, Hermann E, Ringhoffer M, et al. Predominance of Th1 type T cells in synovial fluid of patients with yersinia induced reactive arthritis. Eur J Immunol 1992;22:2771-6.
6. Drazen JM, Arm JP, Austen KF. Sorting out cytokines in asthma. J Exp Med 1996;183:1-3.
7. Xu H, Di Iulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact hypersensitivity are distinguished by polarized patterns of cytokine production: IFN-γ producing (Tc1) effector CD8+ T cells and IL-4/IL-10 producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996;183:1001-11.
8. Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci USA 1982;79:3632-6.
9. Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Forre O, Natvig JB. Rheumatoid inflammatory T cell clones express mostly Th1 but also Th2 and mixed (ThO) cytokine patterns. Scand J Immunol 1993;38:75-82.
10. Bucht A, Larsson P, Weisbrot L, et al. Expression of interferon-gamma, IL-10, IL-12 and transforming growth factor beta mRNA in synovial cells from patients in the early and late phases of rheumatoid arthritis. Clin Exp Immunol 1996;103:357-67.
11. Marcelletti JF, O'Hara JI, Katz DH. Collagen induced arthritis in mice. Relationship of collagen specific and total IgE synthesis to disease. J Immunol 1991;147:4185-91.
12. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin 4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 1992;35:874-83.
13. Loyer P, Ilyin G, Razzak ZA, et al. Interleukin 4 inhibits the production of some acute phase proteins by human hepatocytes in primary culture. FEBS Lett 1995;336:215-20.
14. Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ. Synovial fluid macrophages and blood monocytes differ in their responses to IL-4. J Immunol 1993;151:3370-80.
15. Dechanet J, Briolay J, Rissoan MC, et al. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol 1993;151:4908-17.
16. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldman M. Immunoregulatory role for IL-10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
17. Li L, Elliot JF, Mosmann TR. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 1994;153:3967-78.
18. Chomarat P, Banchereau J, Miossec P. Differential effects of interleukin 10 and 4 on the production of interleukin 6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 1995;38:1046-54.
19. Cush JJ, Splawski JB, Thomas R, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96-104.
20. Cohen SB, Katsikis PD, Chu CQ, et al. High level of interleukin 10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum 1995;38:946-52.
21. Hart PH, Hunt EK, Bonder CS, Watson CJ, Finlay-Jones JJ. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol 1996;157:3672-80.
22. Chomarat P, Vannier E, Dechanet J, et al. Balance of IL-1 receptor antagonist/IL-1ß in rheumatoid arthritis and its regulation by IL-4 and IL-10. J Immunol 1995;154:1432-9.
23. van Roon JA, van Roy JL, Gmelig-Meyling FH, Lafeber FP, Bijlsma JWJ. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
24. De Benedetti F, Robbioni P, Massa M, Viola S, Albani S, Martini A. Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol 1992;10:493-8.
25. De Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994;93:2114-9.
26. Oen K, Danell G. Interleukin 6 and autoantibodies in juvenile rheumatoid arthritis. J Rheumatol 1993;20:1949-56.
27. Rooney M, David J, Symons J, Di Giovine F, Varsani H, Woo P. Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 1995;34:454-60.
28. Eberhard BA, Laxer RM, Andersson U, Silverman ED. Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis. Clin Exp Immunol 1994;96:260-6.
29. Mangge H, Kenzian H, Gallistl S, et al. Serum cytokines in juvenile rheumatoid arthritis: correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995;38:211-20.
30. Madson KL, Moore TL, Lawrence JM III, Osborn TG. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994;21:2359-63.
31. Murray KJ, Luyrink L, Grom AA, et al. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J Rheumatol 1996;23:2116-24.
32. Grom AA, Murray KJ, Luyrink L, et al. Patterns of expression of tumor necrosis factor ß and tumor necrosis factor a and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondyloarthropathy. Arthritis Rheum 1996;39:1703-10.
33. Cassidy JT, Levinson JE, Bass JC, et al. A study of the classification criteria for a diagnosis of JRA. Arthritis Rheum 1986;29:274-81.
34. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
35. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for classification of spondyloarthropathies. Arthritis Rheum 1991;34:1218-27.
36. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277-9.
37. James SP. Detection of cytokine expression by PCR. Curr Protocols Immunol 1995;2:1-10.
38. van Kerckhove C, Melin Aldana H, Elma MS, et al. A distinct HLA-DRw8 haplotype characterizes patients with juvenile rheumatoid arthritis. Immunogenetics 1990;30:304-8.
39. Saunders JR, Murray KJ, Passo MH, Glass DN, Thompson SD. T-cell cytokines reflect disease type in juvenile rheumatoid arthritis [abstract]. Arthritis Rheum 1997;40 Suppl:S242
40. Miossec P, Naviliat M, Dupuy D'Angeac A, Sany J, Banchereau J. Low levels of interleukin-4 and high levels of transforming growth factor-ß in rheumatoid synovitis. Arthritis Rheum 1990;33:1180-7.
41. Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS. Elevated Th1- or Th2-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis: modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol 1995;155:5029-37.
42. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562-6.
43. Brennan FM, Maini RN, Feldmann M. Cytokines in rheumatoid arthritis. In: Brennan FM, Feldmann M, editors. Cytokines in autoimmunity. New York: R.G. Landes; 1996:25-47.
44. Powrie F, Menon S, Coffman RL. Interleukin 4 and interleukin 10 synergize to inhibit cell mediated immunity in vivo. Eur J Immunol 1993;23:3043-9.
45. Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A, Zanussi C. IL-10 upregulates human monocyte phagocytosis in the presence of IL-4 and IFN-γ. J Leukocyte Biol 1995;58:351-8.
46. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor ß, interleukin 4, and prostaglandin E in the brain. J Exp Med 1992;176:1355-64.
47. Racke MK, Bonomo A, Scott DE, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961-6.
48. Chu CQ, Londei M, Induction of Th2 cytokines and control of collagen-induced arthritis by non-depleting anti-CD4 antibodies. J Immunol 1996;157:2685-9.
49. Rocken M, Racke M, Shevach EM. IL-4 induced immune deviation as antigen specific therapy for inflammatory autoimmune disease. Immunol Today 1996;17:225-31.
50. Huhn RD, Radwanski E, O'Connell SM, et al. Pharmokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 1996;87:699-705.
51. Pernice W, Schuchmann L, Dippell J, et al. Therapy for systemic juvenile rheumatoid arthritis with γ-interferon: a pilot study of nine patients. Arthritis Rheum 1989;32:643-6.
52. Murray JS, Madri J, Pasqualini T, Bottomly K. Functional CD4 T cell subset interplay in an intact immune system. J Immunol 1995;150:4270-6.
53. Schountz T, Kasselman JP, Martinson FA, Brown L, Murray JS. MHC genotype controls the capacity of ligand density to switch T helper (Th)-1/Th-2 priming in vivo. J Immunol 1996;157:3893-901.
54. Rink L, Nicklas W, Luhm J, Kruse R, Kirchner H. Induction of a proinflammatory cytokine network by mycoplasma arthritides-derived superantigen (MAS). J Interferon Cytokine Res 1995;16:861-8.
55. Prakken ABJ, Van Eden W, Rijkers GT, et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996;39:1826-32.
56. Murray KJ, Szer W, Grom AA, et al. Antibodies to the 45 kDa DEK nuclear antigen in pauciarticular onset JRA and iridocyclitis: selective association with MHC gene. J Rheumatol 1997;24:560-7.
57. Murray KJ, Grom AA, Glass DN, et al. Patterns of cytokine expression by synovial CD4+ and CD8+ T cells in childhood onset chronic arthritis [abstract]. Arthritis Rheum 1996;39 Suppl:S156.